首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1964256

傳染性鼻炎疫苗市場規模、佔有率和成長分析：按疫苗類型、給藥途徑、應用領域、最終用戶、分銷管道、地區和行業預測，2026-2033年

Infectious Coryza Vaccine Market Size, Share, and Growth Analysis, By Vaccine Type, By Administration Route, By Application Area, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球傳染性鼻炎疫苗市值為8.182億美元，預計將從2025年的8.7793億美元成長到2033年的15.4261億美元。預測期（2026-2033年）的複合年成長率預計為7.3%。

全球傳染性鼻炎疫苗市場對於防治家禽副雞桿菌感染疾病至關重要，該感染會顯著影響雞蛋產量和禽群健康。在全球動物保健公司的推動下，該市場已從小小規模解決方案轉向廣泛應用的去活化疫苗和減毒活病毒疫苗。家禽養殖業的擴張增加了感染風險，也提高了常規疫苗接種的經濟需求。旨在減少抗生素使用的監管政策調整進一步加速了疫苗的普及，尤其是在歐洲和亞洲部分地區，這與公共衛生政策和疫苗推廣部署的擴大相一致。疫苗製劑和物流方面的技術進步為不同血清型的客製化解決方案創造了機會。人工智慧透過最佳化抗原選擇和加速候選疫苗設計來促進疫苗研發，最終提高疫苗的有效性和市場可靠性。

全球傳染性鼻炎疫苗市場促進因素

隨著全球家禽數量的成長，禽群對傳染性鼻炎的易感性也日益增加，凸顯了疫苗接種等預防措施的迫切需求。家禽養殖戶致力於維護禽群健康，以提高生產力並減少損失，這促使疫苗接種計劃得到廣泛實施，並加大對免疫措施的投入。獸醫服務和諮詢網路的建議進一步強調了積極疫苗接種策略的重要性，從而推動了市場需求。這種持續的需求促使生產商擴大產能、豐富疫苗產品種類並加強推廣活動，透過提高疫苗的可及性和普及率，促進了全球傳染性鼻炎疫苗市場的成長。

全球傳染性鼻炎疫苗市場面臨的限制因素

全球傳染性鼻炎疫苗市場面臨諸多限制因素，主要源自於各地監管核准流程的複雜性。這些冗長繁瑣的程序導致產品上市延遲，新疫苗供應迅速短缺，阻礙市場成長。製造商必須應對各種不同的標準和繁瑣的文件要求，導致研發週期延長，合規挑戰加劇。這種環境既會阻礙中小企業採用創新配方，也會限制現有產品的市場推廣。因此，創新應用緩慢，加上終端用戶謹慎的採購慣例，共同限制了整體市場擴張。

全球傳染性鼻炎疫苗市場趨勢

由於綜合農場健康計畫的實施，全球傳染性鼻炎疫苗市場正經歷顯著成長。生產者越來越重視全面預防保健，將疫苗接種、生物安全措施和營養管理協同結合。獸醫和服務供應商實施協調的疫苗接種計劃和農場監測，進一步推動了這一趨勢，從而提升了疫苗在畜牧業健康策略中的價值。對動物福利、穩定生產力和長期降低疾病風險的關注，推動了客製化疫苗配方和綜合支持服務的應用。因此，這種動態環境正在加強與供應商的關係，並在各種家禽養殖場中建立可預測的採購模式。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Zoetis Inc.
Merck Animal Health
Elanco Animal Health
Boehringer Ingelheim Animal Health
Vetoquinol
Hipra
Neogen Corporation
IDT Biologika
Intervet International BV
Phibro Animal Health
Virbac
Biovet
Kemin Industries
Alltech
Cegelec
Jansen Vaccines
Chengdu Hightop Biopharmaceutical
Inovio Pharmaceuticals
Paragon Bioservices
Animal Biotech Industries

結論與建議

簡介目錄

Product Code: SQMIG35J2196

Global Infectious Coryza Vaccine Market size was valued at USD 818.2 Million in 2024 and is poised to grow from USD 877.93 Million in 2025 to USD 1542.61 Million by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global infectious coryza vaccine market is essential for combating Avibacterium paragallinarum infections in poultry, significantly impacting egg production and flock health. The market has transitioned from small-scale solutions to widely accessible inactivated and live attenuated vaccines propelled by global animal health firms. Growing poultry production intensifies transmission risks, thereby increasing the economic imperative for routine vaccination. Regulatory shifts aiming to reduce antibiotic use further incentivize vaccine adoption, particularly in Europe and parts of Asia, where public health policies align with increased vaccine implementation. Technological advancements in vaccine formulation and logistics create opportunities for customized solutions targeting various serovars. AI enhances vaccine development by refining antigen selection and expediting candidate design, ultimately improving the efficacy and reliability of vaccines in the marketplace.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Coryza Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Coryza Vaccine Market Segments Analysis

Global infectious coryza vaccine market is segmented by vaccine type, administration route, application area, end user, distribution channel and region. Based on vaccine type, the market is segmented into Inactivated Vaccine, Live Attenuated Vaccine and Recombinant Vaccine. Based on administration route, the market is segmented into Intramuscular Injection, Subcutaneous Injection and Nasal Spray. Based on application area, the market is segmented into Poultry Farms, Veterinary Clinics and Research Laboratories. Based on end user, the market is segmented into Commercial Producers, Small Scale Farmers and Research Institutions. Based on distribution channel, the market is segmented into Online Sales, Direct Sales and Distributors and Wholesalers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infectious Coryza Vaccine Market

The increasing global poultry population heightens the vulnerability of flocks to infectious coryza, thereby intensifying the perceived necessity for preventive measures such as vaccination. Poultry producers focus on maintaining flock health to boost productivity and minimize losses, leading to a wider implementation of vaccination programs and more robust investment in immunization practices. Recommendations from veterinary services and advisory networks further emphasize the importance of proactive vaccination strategies, bolstering market demand. This ongoing necessity prompts manufacturers to expand production capabilities, diversify their vaccine offerings, and enhance outreach efforts, collectively contributing to the growth of the global infectious coryza vaccine market through improved accessibility and adoption.

Restraints in the Global Infectious Coryza Vaccine Market

The global market for infectious coryza vaccines faces significant constraints due to intricate regulatory approval processes that vary by region. These extended and complex procedures often lead to delays in product launches and limit the swift availability of new vaccines, hindering market growth. Manufacturers must navigate diverse standards and extensive documentation requirements, which lengthen development timelines and elevate compliance challenges. This environment can deter smaller firms from introducing innovative formulations, while also confining the market reach of existing products. Consequently, the slow pace of innovation adoption and cautious procurement practices by end users collectively temper overall market expansion.

Market Trends of the Global Infectious Coryza Vaccine Market

The Global Infectious Coryza Vaccine market is experiencing significant growth driven by the adoption of integrated farm health programs. Producers are increasingly prioritizing comprehensive preventative care that synergizes vaccination, biosecurity measures, and nutrition management. This trend is supported by veterinarians and service providers who are implementing coordinated vaccination schedules and on-farm monitoring, thereby enhancing the perceived value of vaccines in herd health strategies. The emphasis on animal welfare, productivity stability, and long-term disease risk reduction is fostering the adoption of tailored vaccine formulations and comprehensive support services. Consequently, this dynamic landscape is strengthening supplier relationships and establishing predictable procurement patterns across various poultry operations.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Infectious Coryza Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

Market Overview
Inactivated Vaccine
Live Attenuated Vaccine
Recombinant Vaccine

Global Infectious Coryza Vaccine Market Size by Administration Route & CAGR (2026-2033)

Market Overview
Intramuscular Injection
Subcutaneous Injection
Nasal Spray

Global Infectious Coryza Vaccine Market Size by Application Area & CAGR (2026-2033)

Market Overview
Poultry Farms
Veterinary Clinics
Research Laboratories

Global Infectious Coryza Vaccine Market Size by End User & CAGR (2026-2033)

Market Overview
Commercial Producers
Small Scale Farmers
Research Institutions

Global Infectious Coryza Vaccine Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Online Sales
Direct Sales
Distributors and Wholesalers

Global Infectious Coryza Vaccine Market Size & CAGR (2026-2033)

North America (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- US
- Canada
Europe (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hipra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDT Biologika
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intervet International B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phibro Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kemin Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alltech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cegelec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jansen Vaccines
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chengdu Hightop Biopharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paragon Bioservices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Animal Biotech Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments